KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Staar Surgical (STAA) Net Margin (2016 - 2026)

Staar Surgical (STAA) has disclosed Net Margin for 16 consecutive years, with 37.66% as the latest value for Q1 2026.

  • For the quarter ending Q1 2026, Net Margin rose 2493.0% year-over-year to 37.66%, compared with a TTM value of 39.76% through Jan 2026, down 3447.0%, and an annual FY2026 reading of 36.84%, down 3155.0% over the prior year.
  • Net Margin was 37.66% for Q1 2026 at Staar Surgical, down from 9.9% in the prior quarter.
  • Across five years, Net Margin topped out at 78.83% in Q4 2023 and bottomed at 127.29% in Q1 2025.
  • Average Net Margin over 5 years is 7.39%, with a median of 7.01% recorded in 2024.
  • The sharpest move saw Net Margin crashed -796081bps in 2022, then surged 7355bps in 2023.
  • Year by year, Net Margin stood at 5.28% in 2022, then skyrocketed by 1393bps to 78.83% in 2023, then tumbled by -179bps to 62.59% in 2024, then soared by 116bps to 9.9% in 2025, then tumbled by -481bps to 37.66% in 2026.
  • Business Quant data shows Net Margin for STAA at 37.66% in Q1 2026, 9.9% in Q3 2025, and 64.53% in Q2 2025.